A Pilot Comparison Study of Vibrating Mesh Versus Standard Jet Nebuliser for Bronchodilator Delivery in COPD

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

July 31, 2017

Study Completion Date

July 31, 2017

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DEVICE

vibrating mesh nebuliser

The Aerogen Solo vibrating mesh nebuliser is an approved 13 485 class II medical device (CE marked) nebuliser licenced for the delivery of physician-prescribed medications for inhalation which are approved for use with a general purpose nebuliser. It has been shown in previous laboratory and clinical studies to have superior drug delivery to standard jet nebulisers.

DEVICE

Standard hospital jet nebuliser

"The standard hospital jet nebuliser refers to the nebuliser in clinical use currently throughout Beaumont Hospital and used for the administration of nebulised medications"

DRUG

Combined salbutamol 2.5 mg and ipratropium 0.5mg nebule

All patients admitted to hospital with an exacerbation of COPD are administered nebulised bronchodilators (salbutamol 2.5mg/ipratropium 0.5mg combination) as standard of care

Trial Locations (1)

Unknown

Beaumont Hospital, Dublin

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Aerogen

INDUSTRY

lead

Beaumont Hospital

OTHER

NCT02686086 - A Pilot Comparison Study of Vibrating Mesh Versus Standard Jet Nebuliser for Bronchodilator Delivery in COPD | Biotech Hunter | Biotech Hunter